MUNICH, GERMANY, July 21, 2009 -- Nanion’s Patchliner® allows temperature controlled experiments, either at physiological temperatures or by application of temperature jumps.
Here, TRPV1 receptors were activated by noxious temperatures (>42 ˚C) using the temperature regulation feature of the Patchliner®. Solution were heated to temperatures up to 60 ˚C in the pipette and rapidly applied to the cell, transiently activating TRPV1 channels. The temperature responses were compared to capsaicin activation, and could also be blocked by co-application of antagonist and tempered solutions.
Download the TRPV1 application note here.
MUNICH, GERMANY, July 2, 2009 -- During the award ceremony in Berlin, Nanion was announced winner of the Deutscher Gründerpreis 2009. The Deutscher Gründerpreis is the most prestigious award for outstanding entrepreneurs in Germany.
The prize includes coaching by Porsche Consulting and mentorship for Nanion. The mentor for Nanion is Dr. Jürgen Heraeus, Chairman of the Supervisory Board of Heraeus Holding.
Download the complete press release here (English) and here (German).
MUNICH, GERMANY, June 23, 2009 -- Nanion and Axiogenesis present parallel patch clamp recordings of action potentials from Cor.At® Cardiomyocytes Stem cell derived cardiomyocytes were analyzed using Nanion’s Patchliner® and Port-a-patch® to validate the ion channel composition, the presence of action potentials and the effects of compounds on cardiac channels.
Continue Reading
MUNICH, GERMANY, June 3, 2009 -- Nanion is once again nominated for a prestigious award: the German Founder Award (Deutscher Gründerpreis).
For more information about the award (in German):
http://www.deutscher-gruenderpreis.de
